Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Total Debt (2022 - 2025)

Historic Total Debt for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $32.8 million.

  • TriSalus Life Sciences' Total Debt rose 5113.94% to $32.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.8 million, marking a year-over-year increase of 5113.94%. This contributed to the annual value of $22.1 million for FY2024, which is N/A changed from last year.
  • TriSalus Life Sciences' Total Debt amounted to $32.8 million in Q3 2025, which was up 5113.94% from $32.3 million recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Total Debt ranged from a high of $32.8 million in Q3 2025 and a low of $4.7 million during Q1 2023
  • Its 4-year average for Total Debt is $21.4 million, with a median of $21.7 million in 2024.
  • As far as peak fluctuations go, TriSalus Life Sciences' Total Debt soared by 11186.42% in 2024, and later soared by 5113.94% in 2025.
  • Over the past 4 years, TriSalus Life Sciences' Total Debt (Quarter) stood at $15.8 million in 2022, then tumbled by 36.49% to $10.0 million in 2023, then soared by 119.81% to $22.1 million in 2024, then surged by 48.36% to $32.8 million in 2025.
  • Its last three reported values are $32.8 million in Q3 2025, $32.3 million for Q2 2025, and $31.7 million during Q1 2025.